avapro and canagliflozin

avapro has been researched along with canagliflozin in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's4 (100.00)2.80

Authors

AuthorsStudies
Jiang, X; Zhang, FP1
Guo, Y; He, L; Ma, S; Wang, Y; Wang, Z; Zhai, J; Zhang, G; Zhang, T; Zuo, Q1
Guo, Y; He, L; Ma, S; Wang, X; Wang, Y; Wang, Z; Zhai, J; Zhang, G; Zhang, T; Zuo, Q1
Guo, Y; He, L; Ma, S; Wang, X; Wang, Z; Zhai, J; Zhang, G; Zhang, T; Zuo, Q1

Trials

1 trial(s) available for avapro and canagliflozin

ArticleYear
The efficacy and safety of canagliflozin in the treatment of patients with early diabetic nephropathy.
    Journal of physiology and pharmacology : an official journal of the Polish Physiological Society, 2022, Volume: 73, Issue:1

    Topics: Canagliflozin; Diabetic Nephropathies; Humans; Irbesartan; Treatment Outcome

2022

Other Studies

3 other study(ies) available for avapro and canagliflozin

ArticleYear
Canagliflozin ameliorates epithelial-mesenchymal transition in high-salt diet-induced hypertensive renal injury through restoration of sirtuin 3 expression and the reduction of oxidative stress.
    Biochemical and biophysical research communications, 2023, 04-23, Volume: 653

    Topics: Animals; Canagliflozin; Catalase; Diet; Epithelial-Mesenchymal Transition; Fibrosis; Humans; Hypertension; Irbesartan; Kidney; Kidney Diseases; Oxidative Stress; Rats; Rats, Inbred Dahl; Sirtuin 3; Sodium Chloride, Dietary

2023
Canagliflozin Ameliorates Ventricular Remodeling through Apelin/Angiotensin-Converting Enzyme 2 Signaling in Heart Failure with Preserved Ejection Fraction Rats.
    Pharmacology, 2023, Volume: 108, Issue:5

    Topics: Angiotensin-Converting Enzyme 2; Animals; Apelin; Canagliflozin; Fibrosis; Heart Failure; Humans; Irbesartan; Mice; Rats; Rats, Inbred Dahl; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Remodeling

2023
Canagliflozin and irbesartan ameliorate renal fibrosis via the TGF-β1/Smad signaling pathway in Dahl salt-sensitive rats.
    The Journal of international medical research, 2023, Volume: 51, Issue:10

    Topics: Animals; Blood Pressure; Canagliflozin; Fibrosis; Hypertension; Irbesartan; Kidney; Kidney Diseases; Rats; Rats, Inbred Dahl; Signal Transduction; Sodium Chloride; Sodium Chloride, Dietary; Transforming Growth Factor beta1

2023
chemdatabank.com